The global healthcare and laboratory labels market is projected to increase from USD 8.6 billion in 2026 to USD 11.2 billion by 2036, registering a compound annual growth rate (CAGR) of 2.7% over the forecast period. Growth is supported by regulatory identification requirements, laboratory automation, and the need for labels that maintain readability and adhesion under sterilization, chemical exposure, and cold-storage conditions.

The US Food and Drug Administration's 21 CFR 801.45 direct-marking requirements reinforce the need for durable device identification. As labels become integral to medical-device traceability and clinical workflows, healthcare providers and manufacturers must maintain identification throughout the product lifecycle. FMI identifies these compliance requirements, alongside RFID adoption and advanced two-dimensional codes, as factors shaping demand for healthcare and laboratory labels.

Get detailed market forecasts, competitive benchmarking, and pricing trends:
https://www.futuremarketinsights.com/reports/sample/rep-gb-12535 

Global Segment Leaders

• End User: Hospitals, 40.0% share in 2026. Hospitals lead because labels support medication administration, patient identification, specimen collection, sterile processing, and medical-device traceability.
• Diagnostic Laboratories: FMI identifies diagnostic laboratories as an important demand segment as automated specimen handling increases requirements for reliable scanning, sample custody, and identification.
• Pharmaceutical Companies: Demand is supported by drug manufacturing, regulatory traceability, chain-of-identity requirements, and controlled storage conditions.
• Research Institutions: Specialized labels support specimen identification, long-term sample storage, and research workflow integrity.

Segment-share disclosure: The report page explicitly provides a 40.0% share for hospitals. It does not disclose comparable percentage shares for the other end-user categories in the accessible segment analysis. The report also discusses RFID labels, advanced 2D barcodes, smart labeling systems, 1D barcodes, intelligent tags, and direct part marking, but does not provide a verified leading technology share in the published summary.

Country-Level Performance

The report profiles five countries with the following forecast CAGRs and country-specific growth drivers:

• Japan: 4.5% CAGR. FMI links growth to the September 2025 update to Japan's Pharmaceuticals and Medical Devices Act (PMD Act), which the report associates with increased requirements for information-dense labeling and multi-layer booklet labels.
• India: 4.4% CAGR. FMI cites the Central Drugs Standard Control Organisation's early-2026 initiative involving system-generated Neutral Codes for export-specific labeling. The report also references Avery Dennison's India RFID production facility, announced on April 23, 2025, as supporting regional manufacturing capacity.
• China: 4.1% CAGR. FMI identifies National Medical Products Administration Announcement No. 96 (2025) as a driver of labeling protocols for pre-approval commercial-scale batches.
• United States: 3.7% CAGR. The report identifies FDA requirements under 21 CFR 801.45 as a driver of durable identification and traceability requirements for medical devices.
• United Kingdom: 3.5% CAGR. FMI points to standardized procurement, documentation requirements, and demand for labels that withstand hospital sterilization and laboratory automation workflows.

Regional Context

Faster-growing markets: Japan, India, and China. Japan's forecast growth reflects strict identification requirements, demand for information-dense labels, and high expectations for print permanence. India's expansion is associated with healthcare infrastructure development, export-oriented pharmaceutical manufacturing, diagnostic capacity, and increasing adoption of RFID technology. China benefits from manufacturing scale and labeling requirements that encourage readiness for commercial production and regulatory traceability.

Moderate-growth markets: United States and United Kingdom. The United States is expected to expand at 3.7% CAGR as device identification, established healthcare networks, and automation support demand for validated labeling systems. The United Kingdom's 3.5% CAGR reflects compliance-focused procurement, standardized documentation, and demand for durable labels in hospitals and laboratories.

The full report covers North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and the Middle East and Africa. Its scope identifies the United States, United Kingdom, China, Japan, India, and more than 15 additional countries and regional markets.

Competitive Landscape

The key companies profiled by FMI are Avery Dennison, Brady Corporation, 3M, Zebra Technologies, Sato Holdings, Labelmaster, and Lintec Corporation. Competition centers on material durability, label verification, regulatory documentation, intelligent labeling, and integration with printers, scanners, and healthcare information systems.

Two dated developments highlighted in the report are relevant to this competitive landscape:

• April 23, 2025: Avery Dennison announced the opening of its first India-based RFID production facility, supporting regional manufacturing and supply responsiveness.
• June 25, 2025: Avery Dennison announced recognition for an RFID label compatible with the PET recycling stream, reflecting efforts to combine smart-label functionality with recyclability considerations.

FMI's bibliography also records Brady Corporation's acquisition of Mecco on August 4, 2025, expanding its capabilities in direct part marking and durable identification. These developments illustrate how suppliers are expanding manufacturing capacity, identification technologies, and material capabilities to address increasingly demanding healthcare and laboratory workflows.

Related Reports Link: 

https://www.openpr.com/news/4667288/barrier-coated-carton-market-to-reach-usd-8-74-billion-by-2036

https://www.openpr.com/news/4667318/recyclable-lidding-films-market-to-reach-usd-4-7-billion-by-2036

https://www.openpr.com/news/4667364/beauty-and-personal-care-packaging-market-to-reach-usd-94-35 

FMI Custom Research: Strategic Intelligence for Confident Decision-Making

In today's rapidly evolving business environment, leadership teams need more than market data—they need clear, actionable intelligence tailored to their strategic objectives. FMI's Custom Research solutions are designed around the specific business questions organizations need answered, enabling executives to evaluate growth opportunities, validate investments, assess competitive dynamics, and reduce uncertainty before making critical decisions. By combining deep industry expertise, primary research, and proprietary market intelligence, FMI delivers insights that help organizations move from assumptions to evidence-based strategies with greater speed and confidence.

Business Impact

FMI helps organizations transform market complexity into strategic clarity, enabling leadership teams to identify growth opportunities faster, optimize resource allocation, strengthen competitive positioning, and make high-stakes business decisions with confidence.

To explore how FMI Custom Research can support your strategic priorities, please connect with our team at - sales@futuremarketinsights.com 

About Future Market Insights (FMI)

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.